Valuation: Enovis Corporation

Market Cap 1.6B 1.45B 1.34B 1.21B 2.28B 151B 2.36B 16.08B 6.38B 80.44B 5.99B 5.87B 255B P/E 2026 *
-1,107x
P/E 2027 * 50.3x
Enterprise Value 2.9B 2.63B 2.43B 2.19B 4.13B 273B 4.28B 29.2B 11.58B 146B 10.88B 10.65B 464B EV / Sales 2026 *
1.24x
EV / Sales 2027 * 1.16x
Free-Float
98.36%
Yield 2026 *
-
Yield 2027 * -
1 day+0.14%
1 week+1.91%
Current month+39.03%
1 month+43.05%
3 months+6.22%
6 months+13.96%
Current year+3.90%
1 week 27.26
Extreme 27.26
28.92
1 month 19.43
Extreme 19.43
29.89
Current year 16.7
Extreme 16.7
31.66
1 year 16.7
Extreme 16.7
31.66
3 years 16.7
Extreme 16.7
65.03
5 years 16.7
Extreme 16.7
155.34
10 years 16.7
Extreme 16.7
164.01
Manager TitleAgeSince
Chief Executive Officer 61 2025-05-11
Director of Finance/CFO 47 2022-12-31
Chief Tech/Sci/R&D Officer - 2025-12-31
Director TitleAgeSince
Director/Board Member 55 2008-05-12
Director/Board Member 67 2010-09-20
Chairman 64 2025-05-20
Date Insider Type Main position Quantity % Market Cap. Importance
9/30/26 Free

Director

958 0.0017%
9/4/26 Buy

Chief Administrative Officer

2,660 0.0047%
9/4/26 Buy

Chief Executive Officer

13,035 0.0228%
Change 5-day change 1-year change 3-year change Capi.($)
+0.14%+1.91%-7.70%-45.43% 1.6B
+1.18%-1.28%-16.90%+10.73% 188B
+1.85%+1.04%+7.29%+38.96% 126B
-0.88%-4.98%-14.52%+9.17% 118B
+1.36%-5.91%-42.82%+2.34% 92.48B
+2.96%+7.64%-0.80%+85.81% 68.51B
+1.08%+2.90%+12.95%-6.73% 59.39B
+0.89%+4.17%+2.07%+52.91% 55.48B
+0.17%+3.36%+0.19%+46.35% 49.62B
+1.79%+0.10%-0.55%-3.19% 35.17B
Average +1.05%+1.24%-6.08%+19.09% 79B
Weighted average by Cap. +1.09%+0.04%-8.97%+23.62%

Financials

2026 *2027 *
Net sales 2.34B 2.12B 1.96B 1.77B 3.33B 220B 3.45B 23.53B 9.33B 118B 8.77B 8.58B 374B 2.45B 2.22B 2.05B 1.85B 3.49B 231B 3.61B 24.64B 9.77B 123B 9.19B 8.99B 391B
Net income -675K -612K -566K -510K -962K -63.64M -996K -6.8M -2.69M -34M -2.53M -2.48M -108M 23.68M 21.45M 19.84M 17.9M 33.74M 2.23B 34.93M 238M 94.52M 1.19B 88.85M 86.96M 3.79B
Net Debt 1.3B 1.18B 1.09B 985M 1.86B 123B 1.92B 13.12B 5.2B 65.63B 4.89B 4.79B 208B 1.24B 1.12B 1.04B 938M 1.77B 117B 1.83B 12.5B 4.95B 62.5B 4.66B 4.56B 198B
Projected Income Statement - Annual - Enovis Corporation
Logo Enovis Corporation
Enovis Corporation is a medical technology company. It is focused on developing clinically differentiated solutions by manufacturing and distributing high-quality medical devices with a range of products used for reconstructive surgery, rehabilitation, pain management and physical therapy. It operates through two segments: Prevention & Recovery and Reconstructive. The Prevention & Recovery segment provides orthopedic and recovery science solutions, including devices, software, and services across the patient care continuum from injury prevention to rehabilitation after surgery, injury, or from degenerative diseases. The Prevention & Recovery products are marketed under several brand names, such as DJO. The Reconstructive segment provides surgical implant solutions, offering a comprehensive suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and finger and surgical productivity tools. It also operates a Enovis Growth eXcellence business system (EGX).
Employees
7,802
Date Price Change Volume
26-11-13 $27.68 +0.14% 1,205,421
26-11-12 $27.64 -3.19% 1,153,273
26-11-11 $28.55 +1.17% 1,085,031
26-11-10 $28.22 -1.12% 1,596,582
26-11-09 $28.54 +5.08% 1,614,483
Trader
Investor
Global
Quality
ESG MSCI
A
MarketScreener Ratings - Enovis Corporation
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
13
Last Close Price
27.68USD
Average target price
37.83USD
Spread / Average Target
+36.68%
  1. Stock Market
  2. Stocks
  3. ENOV Stock